Theriva™ biologics to present at the 2025 neauxcancer conference

Rockville, md., march 19, 2025 (globe newswire) -- theriva™ biologics (nyse american: tovx), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that the company's management will be attending and presenting at the cancer advocacy group of louisiana (cagla) neauxcancer 2025 conference being held march 27th-29th, 2025 at the roosevelt new orleans hotel in new orleans, la.
TOVX Ratings Summary
TOVX Quant Ranking